Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
Market Analysis and Insights: Global Peptide Based Gastrointestinal Disorders Therapeutics Market
The global Peptide Based Gastrointestinal Disorders Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peptide Based Gastrointestinal Disorders Therapeutics Scope and Market Size
Peptide Based Gastrointestinal Disorders Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Gastrointestinal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical
...
Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
Teduglutide
Linaclotide
Others
Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market Analysis and Insights: Global Peptide Based Gastrointestinal Disorders Therapeutics Market
The global Peptide Based Gastrointestinal Disorders Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peptide Based Gastrointestinal Disorders Therapeutics Scope and Market Size
Peptide Based Gastrointestinal Disorders Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Gastrointestinal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical
...
Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
Teduglutide
Linaclotide
Others
Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Teduglutide
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2015-2026)
2.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Peptide Based Gastrointestinal Disorders Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Market Size
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2019
3.3 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.4 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
3.5 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
6.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in North America (2019-2020)
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
7.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
8.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in China (2019-2020)
8.3 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
8.4 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
9.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
9.4 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
10.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
11.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in India (2019-2020)
11.3 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
11.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
12.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 Ironwood Pharmaceuticals
13.2.1 Ironwood Pharmaceuticals Company Details
13.2.2 Ironwood Pharmaceuticals Business Overview
13.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.2.5 Ironwood Pharmaceuticals Recent Development
13.3 Astellas Pharma
13.3.1 Astellas Pharma Company Details
13.3.2 Astellas Pharma Business Overview
13.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.3.5 Astellas Pharma Recent Development
13.4 Allergan
13.4.1 Allergan Company Details
13.4.2 Allergan Business Overview
13.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.4.5 Allergan Recent Development
13.5 Takeda Pharmaceutical
13.5.1 Takeda Pharmaceutical Company Details
13.5.2 Takeda Pharmaceutical Business Overview
13.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.5.5 Takeda Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Teduglutide
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2015-2026)
2.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Peptide Based Gastrointestinal Disorders Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Market Size
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2019
3.3 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.4 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
3.5 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
6.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in North America (2019-2020)
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
7.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
8.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in China (2019-2020)
8.3 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
8.4 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
9.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
9.4 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
10.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
11.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in India (2019-2020)
11.3 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
11.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2015-2020)
12.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 Ironwood Pharmaceuticals
13.2.1 Ironwood Pharmaceuticals Company Details
13.2.2 Ironwood Pharmaceuticals Business Overview
13.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.2.5 Ironwood Pharmaceuticals Recent Development
13.3 Astellas Pharma
13.3.1 Astellas Pharma Company Details
13.3.2 Astellas Pharma Business Overview
13.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.3.5 Astellas Pharma Recent Development
13.4 Allergan
13.4.1 Allergan Company Details
13.4.2 Allergan Business Overview
13.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.4.5 Allergan Recent Development
13.5 Takeda Pharmaceutical
13.5.1 Takeda Pharmaceutical Company Details
13.5.2 Takeda Pharmaceutical Business Overview
13.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
13.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2015-2020)
13.5.5 Takeda Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
